Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genomac Institute is a biotechnology organization focused on the convergence of genomics, bioinformatics, and artificial intelligence to address global health challenges. Operating as a core division of Genomac Holdings, the institute specializes in capacity building, having trained thousands of life scientists across more than 100 countries in advanced omics technologies. Its research and development efforts are primarily focused on drug discovery from African medicinal plants and the development of precision medicine solutions. The institute also operates an innovation hub (G-iHub) to incubate and scale health-tech and deep-tech startups. Through subsidiaries like G-NATURES and Genomac Labs, the organization bridges the gap between scientific research and commercial healthcare applications. Genomac Institute maintains a strong strategic focus on transforming the African biotechnology landscape while maintaining a global research and education network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genomac Institute.